Managing CLL treatment in the future: targeted therapies and early intervention

Comparing Early vs. Delayed Therapy for Chronic Lymphocytic Leukemia (CLL) - ASH 2021Подробнее

Targeted Therapy Options for Frontline CLLПодробнее

Future advancements in the treatment of CLLПодробнее

The LATEST in Chronic Lymphocytic Leukemia (CLL) Treatments! | The Patient StoryПодробнее

The Future of CLL ManagementПодробнее

The future of CLL treatment: chemotherapy and targeted inhibitorsПодробнее

Fixed duration treatment strategies in CLLПодробнее

Targeted therapy in CLL in 2022 and in the futureПодробнее

Targeted therapies for CLLПодробнее

Treatment options for the young CLL patient with deletion 17p: Do they need a different approach?Подробнее

Emerging Themes in Targeted Therapy Research for CLLПодробнее

Crafting the New Treatment Mix in CLLПодробнее

New Treatment Guidelines to Chronic Lymphocytic Leukemia (CLL): Latest advances & treatmentsПодробнее

The future of CLL treatment: aiming for long-lasting remissionПодробнее

Why drug combinations are the future of treatment in CLLПодробнее

Management of CLL in 2021 and BeyondПодробнее

The latest CLL treatments and therapies with Dr Jan BurgerПодробнее

Case 3: Managing Ibrutinib-Associated Toxicities in CLLПодробнее

New frontiers and emerging treatments for CLLПодробнее